Effect of Preoperative Tricuspid and/or Mitral Regurgitation on Development of Late Right-Sided Heart Failure After Insertion of the HeartWare Left Ventricular Assist Device.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 24 08 2019
revised: 01 10 2019
accepted: 03 10 2019
pubmed: 27 11 2019
medline: 23 4 2020
entrez: 27 11 2019
Statut: ppublish

Résumé

Right-sided heart failure (RHF) after left ventricular assist device implantation is a significant cause of morbidity and mortality. Although multiple predictors of early RHF have been described, information on late RHF is scarce. The aim of this study was to identify predictors of late RHF in left ventricular assist device patients. A retrospective analysis of all adult patients who underwent HeartWare-ventricular assist device implantation as a bridge to transplantation in a single-centre was performed. Late RHF was defined as RHF requiring rehospitalization after 30 days of implantation. A total of 16 (10.3%) patients from 156 implantations developed late RHF. Median time to late RHF onset was 182.5 (interquartile range 105 to 618) days. Patients developing late RHF were older at surgery. A significantly higher rate of moderate or severe tricuspid regurgitation before implantation was found in patients presenting with late RHF (81.2% vs 33.5%; p <0.001). Several echocardiographic parameters at discharge postimplant, such as significant mitral regurgitation, demonstrated a strong association with late RHF. A multivariate Cox regression analysis revealed that significant preoperative tricuspid regurgitation was the strongest predictor of late RHF (hazard ratio 5.50, 95% confidence interval [1.34 to 22.58]; p = 0.02). Significant mitral regurgitation postimplantation and older age also significantly predicted late RHF. In conclusion, preoperative significant tricuspid regurgitation and mitral regurgitation after implantation predict the occurrence of late RHF.

Identifiants

pubmed: 31767121
pii: S0002-9149(19)31151-8
doi: 10.1016/j.amjcard.2019.10.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-243

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Auteurs

Oscar Gonzalez-Fernandez (O)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; Universidad Autonoma de Madrid, Madrid, Spain. Electronic address: ojog_1@hotmail.com.

Noelia Bouzas-Cruz (N)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Carlos Ferrera (C)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Andrew Woods (A)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Nicola Robinson-Smith (N)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Sian Tovey (S)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Gareth Parry (G)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Guy Andrew MacGowan (GA)

Departments of Cardiology and Cardiothoracic Surgery, Freeman Hospital Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Stephan Schueler (S)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH